Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Misregulation of tau alternative splicing in neurodegeneration and dementia.

Andreadis A.

Prog Mol Subcell Biol. 2006;44:89-107. Review.

PMID:
17076266
2.

Tau splicing and the intricacies of dementia.

Andreadis A.

J Cell Physiol. 2012 Mar;227(3):1220-5. doi: 10.1002/jcp.22842. Review.

4.

Regulation of tau isoform expression and dementia.

D'Souza I, Schellenberg GD.

Biochim Biophys Acta. 2005 Jan 3;1739(2-3):104-15. Review.

5.

[Tau story: from frontotemporal dementia to other tauopathies].

Buée L, Hamdane M, Delobel P, Sambo AV, Bégard S, Ghestem A, Sergeant N, Delacourte A.

J Soc Biol. 2002;196(1):103-8. Review. French.

PMID:
12134624
6.
7.

Tau protein in familial and sporadic diseases.

Yancopoulou D, Spillantini MG.

Neuromolecular Med. 2003;4(1-2):37-48. Review.

PMID:
14528051
8.
9.

Regulation of alternative splicing of tau exon 10.

Qian W, Liu F.

Neurosci Bull. 2014 Apr;30(2):367-77. doi: 10.1007/s12264-013-1411-2. Epub 2014 Mar 14. Review.

PMID:
24627328
10.

Tau phosphorylation in neuronal cell function and dysfunction.

Johnson GV, Stoothoff WH.

J Cell Sci. 2004 Nov 15;117(Pt 24):5721-9. Review.

11.

Transcriptional and conformational changes of the tau molecule in Alzheimer's disease.

Hyman BT, Augustinack JC, Ingelsson M.

Biochim Biophys Acta. 2005 Jan 3;1739(2-3):150-7. Review.

12.

Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.

Zhou J, Yu Q, Zou T.

BMC Neurosci. 2008 Dec 3;9 Suppl 2:S10. doi: 10.1186/1471-2202-9-S2-S10. Review.

13.

The role of tau phosphorylation and cleavage in neuronal cell death.

Chun W, Johnson GV.

Front Biosci. 2007 Jan 1;12:733-56. Review.

PMID:
17127334
14.

[Tau protein abnormality and dementia: the mechanisms of neurodegeneration].

Tanaka T, Takeda M.

No To Shinkei. 2002 Sep;54(9):777-87. Review. Japanese. No abstract available.

PMID:
12428364
15.

Microtubule-associated protein tau in development, degeneration and protection of neurons.

Wang JZ, Liu F.

Prog Neurobiol. 2008 Jun;85(2):148-75. doi: 10.1016/j.pneurobio.2008.03.002. Epub 2008 Mar 22. Review.

PMID:
18448228
16.

Tau-based treatment strategies in neurodegenerative diseases.

Schneider A, Mandelkow E.

Neurotherapeutics. 2008 Jul;5(3):443-57. doi: 10.1016/j.nurt.2008.05.006. Review.

PMID:
18625456
17.

Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.

Pei JJ, Sjögren M, Winblad B.

Curr Opin Psychiatry. 2008 Nov;21(6):555-61. doi: 10.1097/YCO.0b013e328314b78b. Review.

PMID:
18852562
18.

Hereditary frontotemporal dementia caused by Tau gene mutations.

van Swieten J, Spillantini MG.

Brain Pathol. 2007 Jan;17(1):63-73. Review.

PMID:
17493040
19.

Frontotemporal dementia with tau pathology.

Gasparini L, Terni B, Spillantini MG.

Neurodegener Dis. 2007;4(2-3):236-53. Review.

PMID:
17596718
20.

Genotype-phenotype correlations in FTDP-17: does form follow function?

Forman MS.

Exp Neurol. 2004 Jun;187(2):229-34. Review. No abstract available.

PMID:
15144848
Items per page

Supplemental Content

Write to the Help Desk